Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma

BACKGROUND: Indoleamine 2,3-dioxygenase (IDO) is an interferon-inducible immune checkpoint expressed on tumor-infiltrating lymphocytes (TILs). IDO is known as a poor prognostic marker in esophageal squamous cell cancer, while a positive effect was shown for breast cancer. A comprehensive analysis of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunol Res
Main Authors: Loeser, Heike, Kraemer, Max, Gebauer, Florian, Bruns, Christiane, Schröder, Wolfgang, Zander, Thomas, Alakus, Hakan, Hoelscher, Arnulf, Buettner, Reinhard, Lohneis, Philipp, Quaas, Alexander
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2020
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527882/
https://ncbi.nlm.nih.gov/pubmed/33029538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2862647
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker